{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:48:15Z","timestamp":1786981695908,"version":"build-2736575974"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,3,26]],"date-time":"2022-03-26T00:00:00Z","timestamp":1648252800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Bundeswehr Medical Service\u2019s Biodefence research programme"},{"DOI":"10.13039\/100009139","name":"Deutsches Zentrum f\u00fcr Infektionsforschung","doi-asserted-by":"publisher","award":["TI 07.003 MD Programme-Hucke"],"award-info":[{"award-number":["TI 07.003 MD Programme-Hucke"]}],"id":[{"id":"10.13039\/100009139","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Zoonoses Sequencing Network BMBF-ZooSeq","award":["01KI1905A"],"award-info":[{"award-number":["01KI1905A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virus Genes"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s11262-022-01892-x","type":"journal-article","created":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T21:03:41Z","timestamp":1648501421000},"page":"188-202","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251"],"prefix":"10.1007","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5396-723X","authenticated-orcid":false,"given":"Friederike I. L.","family":"Hucke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malena","family":"Bestehorn-Willmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Bassetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Brancale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Zanetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim J.","family":"Bugert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,26]]},"reference":[{"key":"1892_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1002\/9781118644843.ch9","volume-title":"Human emerging and re-emerging infections: viral & parasitic infections","author":"SK Singh","year":"2015","unstructured":"Singh SK (2015) Overview on chikungunya virus pathogenesis. In: Singh SK (ed) Human emerging and re-emerging infections: viral & parasitic infections. Wiley, New Jersey, pp 177\u2013188"},{"issue":"Pt 2","key":"1892_CR2","first-page":"471","volume":"81","author":"AM Powers","year":"2000","unstructured":"Powers AM et al (2000) Re-emergence of Chikungunya and O\u2019nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships. J Gen Virol 81(Pt 2):471\u2013479","journal-title":"J Gen Virol"},{"issue":"7","key":"1892_CR3","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1371\/journal.pmed.0030263","volume":"3","author":"I Schuffenecker","year":"2006","unstructured":"Schuffenecker I et al (2006) Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak. PLoS Med 3(7):e263","journal-title":"PLoS Med"},{"issue":"2","key":"1892_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/v10020089","volume":"10","author":"RS Brown","year":"2018","unstructured":"Brown RS, Wan JJ, Kielian M (2018) The alphavirus exit pathway: what we know and what we wish we knew. Viruses 10(2):89","journal-title":"Viruses"},{"key":"1892_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s11262-020-01820-x","volume":"57","author":"FIL Hucke","year":"2020","unstructured":"Hucke FIL, Bestehorn-Willmann M, Bugert JJ (2020) Prophylactic strategies to control Chikungunya virus infection. Virus Genes 57:133","journal-title":"Virus Genes"},{"key":"1892_CR6","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3389\/fpubh.2020.618624","volume":"8","author":"FIL Hucke","year":"2020","unstructured":"Hucke FIL, Bugert JJ (2020) Current and promising antivirals against chikungunya virus. Front Public Health 8:916","journal-title":"Front Public Health"},{"issue":"2","key":"1892_CR7","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3390\/v11020175","volume":"11","author":"G Matusali","year":"2019","unstructured":"Matusali G et al (2019) Tropism of the Chikungunya virus. Viruses 11(2):175","journal-title":"Viruses"},{"issue":"7706","key":"1892_CR8","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1038\/s41586-018-0121-3","volume":"557","author":"R Zhang","year":"2018","unstructured":"Zhang R et al (2018) Mxra8 is a receptor for multiple arthritogenic alphaviruses. Nature 557(7706):570\u2013574","journal-title":"Nature"},{"key":"1892_CR9","doi-asserted-by":"publisher","first-page":"32288","DOI":"10.1038\/srep32288","volume":"6","author":"M Ruiz Silva","year":"2016","unstructured":"Ruiz Silva M et al (2016) Mechanism and role of MCP-1 upregulation upon chikungunya virus infection in human peripheral blood mononuclear cells. Sci Rep 6:32288","journal-title":"Sci Rep"},{"key":"1892_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/1743-422X-5-31","volume":"5","author":"S Lokireddy","year":"2008","unstructured":"Lokireddy S, Vemula S, Vadde R (2008) Connective tissue metabolism in chikungunya patients. Virol J 5:31","journal-title":"Virol J"},{"issue":"3","key":"1892_CR11","doi-asserted-by":"publisher","first-page":"e1978","DOI":"10.1002\/rmv.1978","volume":"28","author":"R Mehta","year":"2018","unstructured":"Mehta R et al (2018) The neurological complications of chikungunya virus: a systematic review. Rev Med Virol 28(3):e1978","journal-title":"Rev Med Virol"},{"issue":"3","key":"1892_CR12","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s12028-017-0413-8","volume":"27","author":"T Cerny","year":"2017","unstructured":"Cerny T et al (2017) The range of neurological complications in Chikungunya fever. Neurocrit Care 27(3):447\u2013457","journal-title":"Neurocrit Care"},{"issue":"Pt 2","key":"1892_CR13","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1099\/vir.0.071175-0","volume":"96","author":"T Das","year":"2015","unstructured":"Das T et al (2015) Multifaceted innate immune responses engaged by astrocytes, microglia and resident dendritic cells against Chikungunya neuroinfection. J Gen Virol 96(Pt 2):294\u2013310","journal-title":"J Gen Virol"},{"key":"1892_CR14","first-page":"1201","volume":"21","author":"YK Yasumura","year":"1963","unstructured":"Yasumura YK (1963) Studies on SV40 in tissue culture-preliminary step for cancer research in vitro. Nihon Rinsho 21:1201\u20131215","journal-title":"Nihon Rinsho"},{"issue":"1","key":"1892_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/ijc.2910170110","volume":"17","author":"M Lieber","year":"1976","unstructured":"Lieber M et al (1976) A continuous tumor-cell line from a human lung carcinoma with properties of type II alveolar epithelial cells. Int J Cancer 17(1):62\u201370","journal-title":"Int J Cancer"},{"issue":"9","key":"1892_CR16","first-page":"3858","volume":"42","author":"H Nakabayashi","year":"1982","unstructured":"Nakabayashi H et al (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42(9):3858\u20133863","journal-title":"Cancer Res"},{"issue":"9-10","key":"1892_CR17","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/BF02631035","volume":"28","author":"CA Kruse","year":"1992","unstructured":"Kruse CA et al (1992) Characterization of a continuous human glioma cell line DBTRG-05MG: growth kinetics, karyotype, receptor expression, and tumor suppressor gene analyses. In Vitro Cell Dev Biol 28(9\u201310):609\u2013614","journal-title":"In Vitro Cell Dev Biol"},{"issue":"2","key":"1892_CR18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1017\/S0022172400044442","volume":"54","author":"RW Ross","year":"1956","unstructured":"Ross RW (1956) The Newala epidemic. III. The virus: isolation, pathogenic properties and relationship to the epidemic. J Hyg (Lond) 54(2):177\u2013191","journal-title":"J Hyg (Lond)"},{"issue":"Pt 7","key":"1892_CR19","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1099\/vir.0.82714-0","volume":"88","author":"VA Arankalle","year":"2007","unstructured":"Arankalle VA et al (2007) Genetic divergence of Chikungunya viruses in India (1963\u20132006) with special reference to the 2005\u20132006 explosive epidemic. J Gen Virol 88(Pt 7):1967\u20131976","journal-title":"J Gen Virol"},{"issue":"13","key":"1892_CR20","doi-asserted-by":"publisher","first-page":"6497","DOI":"10.1128\/JVI.01603-09","volume":"84","author":"SM Volk","year":"2010","unstructured":"Volk SM et al (2010) Genome-scale phylogenetic analyses of chikungunya virus reveal independent emergences of recent epidemics and various evolutionary rates. J Virol 84(13):6497\u20136504","journal-title":"J Virol"},{"issue":"8","key":"1892_CR21","doi-asserted-by":"publisher","first-page":"e71047","DOI":"10.1371\/journal.pone.0071047","volume":"8","author":"FE Scholte","year":"2013","unstructured":"Scholte FE et al (2013) Characterization of synthetic Chikungunya viruses based on the consensus sequence of recent E1\u2013226V isolates. PLoS ONE 8(8):e71047","journal-title":"PLoS ONE"},{"issue":"10","key":"1892_CR22","doi-asserted-by":"publisher","first-page":"2770","DOI":"10.1093\/jac\/dku209","volume":"69","author":"L Delang","year":"2014","unstructured":"Delang L et al (2014) Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. J Antimicrob Chemother 69(10):2770\u20132784","journal-title":"J Antimicrob Chemother"},{"issue":"6","key":"1892_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.4103\/ijmr.IJMR_453_17","volume":"149","author":"AB Sudeep","year":"2019","unstructured":"Sudeep AB et al (2019) Differential susceptibility & replication potential of Vero E6, BHK-21, RD, A-549, C6\/36 cells & Aedes aegypti mosquitoes to three strains of chikungunya virus. Indian J Med Res 149(6):771\u2013777","journal-title":"Indian J Med Res"},{"issue":"9","key":"1892_CR24","doi-asserted-by":"publisher","first-page":"e75854","DOI":"10.1371\/journal.pone.0075854","volume":"8","author":"R Abraham","year":"2013","unstructured":"Abraham R et al (2013) Induction of cytopathogenicity in human glioblastoma cells by chikungunya virus. PLoS ONE 8(9):e75854","journal-title":"PLoS ONE"},{"issue":"354","key":"1892_CR25","doi-asserted-by":"publisher","first-page":"35re43","DOI":"10.1126\/scitranslmed.aaf6853","volume":"8","author":"M Allen","year":"2016","unstructured":"Allen M et al (2016) Origin of the U87MG glioma cell line: good news and bad news. Sci Transl Med 8(354):35re43","journal-title":"Sci Transl Med"},{"issue":"4","key":"1892_CR26","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1111\/j.1699-0463.1968.tb03502.x","volume":"74","author":"J Pont\u00e9n","year":"1968","unstructured":"Pont\u00e9n J, Macintyre EH (1968) Long term culture of normal and neoplastic human glia. Acta Pathol Microbiol Scand 74(4):465\u2013486","journal-title":"Acta Pathol Microbiol Scand"},{"issue":"4","key":"1892_CR27","first-page":"184","volume":"56","author":"J Pont\u00e9n","year":"1978","unstructured":"Pont\u00e9n J, Westermark B (1978) Properties of human malignant glioma cells in vitro. Med Biol 56(4):184\u2013193","journal-title":"Med Biol"},{"issue":"6","key":"1892_CR28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1002\/(SICI)1097-0215(19981218)79:6<640::AID-IJC15>3.0.CO;2-Z","volume":"79","author":"M Weller","year":"1998","unstructured":"Weller M et al (1998) Predicting chemoresistance in human malignant glioma cells: the role of molecular genetic analyses. Int J Cancer 79(6):640\u2013644","journal-title":"Int J Cancer"},{"issue":"6","key":"1892_CR29","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1371\/journal.ppat.0030089","volume":"3","author":"M Sourisseau","year":"2007","unstructured":"Sourisseau M et al (2007) Characterization of reemerging chikungunya virus. PLoS Pathog 3(6):e89","journal-title":"PLoS Pathog"},{"issue":"2","key":"1892_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.virol.2009.07.024","volume":"393","author":"M Solignat","year":"2009","unstructured":"Solignat M et al (2009) Replication cycle of chikungunya: a re-emerging arbovirus. Virology 393(2):183\u2013197","journal-title":"Virology"},{"issue":"8","key":"1892_CR31","doi-asserted-by":"publisher","first-page":"4180","DOI":"10.1128\/JVI.03114-13","volume":"88","author":"D Olagnier","year":"2014","unstructured":"Olagnier D et al (2014) Inhibition of dengue and chikungunya virus infections by RIG-I-mediated type I interferon-independent stimulation of the innate antiviral response. J Virol 88(8):4180\u20134194","journal-title":"J Virol"},{"key":"1892_CR32","doi-asserted-by":"publisher","first-page":"204020661880758","DOI":"10.1177\/2040206618807580","volume":"26","author":"EJ Franco","year":"2018","unstructured":"Franco EJ et al (2018) The effectiveness of antiviral agents with broad-spectrum activity against chikungunya virus varies between host cell lines. Antivir Chem Chemother 26:2040206618807580","journal-title":"Antivir Chem Chemother"},{"issue":"1","key":"1892_CR33","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00204-011-0733-y","volume":"86","author":"J Lin","year":"2012","unstructured":"Lin J et al (2012) Comparative analysis of phase I and II enzyme activities in 5 hepatic cell lines identifies Huh-7 and HCC-T cells with the highest potential to study drug metabolism. Arch Toxicol 86(1):87\u201395","journal-title":"Arch Toxicol"},{"issue":"1","key":"1892_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000339985","volume":"56","author":"YG Li","year":"2013","unstructured":"Li YG et al (2013) Chikungunya virus induces a more moderate cytopathic effect in mosquito cells than in mammalian cells. Intervirology 56(1):6\u201312","journal-title":"Intervirology"},{"issue":"2","key":"1892_CR35","doi-asserted-by":"publisher","first-page":"e01389","DOI":"10.1128\/AAC.01389-18","volume":"63","author":"AC Ferreira","year":"2019","unstructured":"Ferreira AC et al (2019) Beyond members of the flaviviridae family, sofosbuvir also inhibits chikungunya virus replication. Antimicrob Agents Chemother 63(2):e01389","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"1892_CR36","doi-asserted-by":"publisher","first-page":"14641","DOI":"10.1038\/s41598-017-15269-w","volume":"7","author":"GC Roberts","year":"2017","unstructured":"Roberts GC et al (2017) Evaluation of a range of mammalian and mosquito cell lines for use in Chikungunya virus research. Sci Rep 7(1):14641\u201314641","journal-title":"Sci Rep"},{"issue":"8","key":"1892_CR37","first-page":"e93","volume":"5","author":"JF Chan","year":"2016","unstructured":"Chan JF et al (2016) Differential cell line susceptibility to the emerging Zika virus: implications for disease pathogenesis, non-vector-borne human transmission and animal reservoirs. Emerg Microbes Infect 5(8):e93","journal-title":"Emerg Microbes Infect"},{"key":"1892_CR38","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.virusres.2017.11.003","volume":"244","author":"I Vicenti","year":"2018","unstructured":"Vicenti I et al (2018) Comparative analysis of different cell systems for Zika virus (ZIKV) propagation and evaluation of anti-ZIKV compounds in vitro. Virus Res 244:64\u201370","journal-title":"Virus Res"},{"issue":"5","key":"1892_CR39","doi-asserted-by":"publisher","first-page":"771","DOI":"10.3390\/v13050771","volume":"13","author":"EJ Franco","year":"2021","unstructured":"Franco EJ, Pires de Mello CP, Brown AN (2021) Antiviral evaluation of UV-4B and interferon-alpha combination regimens against dengue virus. Viruses 13(5):771","journal-title":"Viruses"},{"issue":"1","key":"1892_CR40","doi-asserted-by":"publisher","first-page":"e31102","DOI":"10.1371\/journal.pone.0031102","volume":"7","author":"N Wikan","year":"2012","unstructured":"Wikan N et al (2012) Chikungunya virus infection of cell lines: analysis of the East, Central and South African lineage. PLoS ONE 7(1):e31102","journal-title":"PLoS ONE"},{"issue":"21","key":"1892_CR41","doi-asserted-by":"publisher","first-page":"12180","DOI":"10.1128\/JVI.01672-14","volume":"88","author":"AW Ashbrook","year":"2014","unstructured":"Ashbrook AW et al (2014) Residue 82 of the Chikungunya virus E2 attachment protein modulates viral dissemination and arthritis in mice. J Virol 88(21):12180\u201312192","journal-title":"J Virol"},{"issue":"3","key":"1892_CR42","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/0264-410X(86)90003-4","volume":"4","author":"NH Levitt","year":"1986","unstructured":"Levitt NH et al (1986) Development of an attenuated strain of chikungunya virus for use in vaccine production. Vaccine 4(3):157\u2013162","journal-title":"Vaccine"},{"issue":"2","key":"1892_CR43","doi-asserted-by":"publisher","first-page":"e2719","DOI":"10.1371\/journal.pntd.0002719","volume":"8","author":"CL Gardner","year":"2014","unstructured":"Gardner CL et al (2014) Deliberate attenuation of chikungunya virus by adaptation to heparan sulfate-dependent infectivity: a model for rational arboviral vaccine design. PLoS Negl Trop Dis 8(2):e2719","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"1892_CR44","doi-asserted-by":"publisher","first-page":"2385","DOI":"10.1128\/JVI.03116-13","volume":"88","author":"LA Silva","year":"2014","unstructured":"Silva LA et al (2014) A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol 88(5):2385\u20132397","journal-title":"J Virol"},{"issue":"11","key":"1892_CR45","doi-asserted-by":"publisher","first-page":"6084","DOI":"10.1128\/JVI.06449-11","volume":"86","author":"R Gorchakov","year":"2012","unstructured":"Gorchakov R et al (2012) Attenuation of Chikungunya virus vaccine strain 181\/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein. J Virol 86(11):6084\u20136096","journal-title":"J Virol"},{"issue":"11","key":"1892_CR46","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/v11111078","volume":"11","author":"BS Schnierle","year":"2019","unstructured":"Schnierle BS (2019) Cellular attachment and entry factors for chikungunya virus. Viruses 11(11):1078","journal-title":"Viruses"},{"issue":"1","key":"1892_CR47","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.virol.2012.07.019","volume":"434","author":"H Henrik Gad","year":"2012","unstructured":"Henrik Gad H et al (2012) The E2\u2013E166K substitution restores Chikungunya virus growth in OAS3 expressing cells by acting on viral entry. Virology 434(1):27\u201337","journal-title":"Virology"},{"issue":"38","key":"1892_CR48","doi-asserted-by":"publisher","first-page":"16038","DOI":"10.1073\/pnas.1111650108","volume":"108","author":"LL Coffey","year":"2011","unstructured":"Coffey LL et al (2011) Arbovirus high fidelity variant loses fitness in mosquitoes and mice. Proc Natl Acad Sci USA 108(38):16038\u201316043","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1892_CR49","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/0042-6822(91)90114-Q","volume":"183","author":"NL Davis","year":"1991","unstructured":"Davis NL et al (1991) Attenuating mutations in the E2 glycoprotein gene of Venezuelan equine encephalitis virus: construction of single and multiple mutants in a full-length cDNA clone. Virology 183(1):20\u201331","journal-title":"Virology"},{"issue":"9","key":"1892_CR50","doi-asserted-by":"publisher","first-page":"7357","DOI":"10.1128\/JVI.72.9.7357-7366.1998","volume":"72","author":"WB Klimstra","year":"1998","unstructured":"Klimstra WB, Ryman KD, Johnston RE (1998) Adaptation of Sindbis virus to BHK cells selects for use of heparan sulfate as an attachment receptor. J Virol 72(9):7357\u20137366","journal-title":"J Virol"},{"issue":"5","key":"1892_CR51","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.4269\/ajtmh.18-0980","volume":"100","author":"I Maljkovic Berry","year":"2019","unstructured":"Maljkovic Berry I et al (2019) Global outbreaks and origins of a chikungunya virus variant carrying mutations which may increase fitness for Aedes aegypti: revelations from the 2016 Mandera, Kenya Outbreak. Am J Trop Med Hyg 100(5):1249\u20131257","journal-title":"Am J Trop Med Hyg"},{"issue":"16","key":"1892_CR52","doi-asserted-by":"publisher","first-page":"8879","DOI":"10.1128\/JVI.00370-12","volume":"86","author":"W Akahata","year":"2012","unstructured":"Akahata W, Nabel GJ (2012) A specific domain of the Chikungunya virus E2 protein regulates particle formation in human cells: implications for alphavirus vaccine design. J Virol 86(16):8879\u20138883","journal-title":"J Virol"},{"issue":"17","key":"1892_CR53","doi-asserted-by":"publisher","first-page":"8329","DOI":"10.1128\/JVI.75.17.8329-8339.2001","volume":"75","author":"YE Lu","year":"2001","unstructured":"Lu YE et al (2001) In vivo generation and characterization of a soluble form of the Semliki forest virus fusion protein. J Virol 75(17):8329\u20138339","journal-title":"J Virol"},{"issue":"12","key":"1892_CR54","doi-asserted-by":"publisher","first-page":"e1002412","DOI":"10.1371\/journal.ppat.1002412","volume":"7","author":"KA Tsetsarkin","year":"2011","unstructured":"Tsetsarkin KA, Weaver SC (2011) Sequential adaptive mutations enhance efficient vector switching by Chikungunya virus and its epidemic emergence. PLoS Pathog 7(12):e1002412\u2013e1002412","journal-title":"PLoS Pathog"},{"key":"1892_CR55","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1186\/1743-422X-8-376","volume":"8","author":"KA Tsetsarkin","year":"2011","unstructured":"Tsetsarkin KA, McGee CE, Higgs S (2011) Chikungunya virus adaptation to Aedes albopictus mosquitoes does not correlate with acquisition of cholesterol dependence or decreased pH threshold for fusion reaction. Virol J 8:376","journal-title":"Virol J"},{"issue":"6","key":"1892_CR56","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.meegid.2012.02.003","volume":"12","author":"B Gay","year":"2012","unstructured":"Gay B et al (2012) pH-dependent entry of chikungunya virus into Aedes albopictus cells. Infect Genet Evol 12(6):1275\u20131281","journal-title":"Infect Genet Evol"},{"key":"1892_CR57","doi-asserted-by":"publisher","DOI":"10.1007\/s43188-021-00101-5","author":"F Askarian","year":"2021","unstructured":"Askarian F et al (2021) A review on the pharmacokinetic properties and toxicity considerations for chloroquine and hydroxychloroquine to potentially treat coronavirus patients. Toxicol Res. https:\/\/doi.org\/10.1007\/s43188-021-00101-5","journal-title":"Toxicol Res"},{"issue":"23","key":"1892_CR58","doi-asserted-by":"publisher","first-page":"e01561","DOI":"10.1128\/JVI.01561-20","volume":"94","author":"B Sahoo","year":"2020","unstructured":"Sahoo B, Gudigamolla NK, Chowdary TK (2020) Acidic pH-induced conformational changes in chikungunya virus fusion protein E1: a spring-twisted region in the domain I-III linker acts as a hinge point for swiveling motion of domains. J Virol 94(23):e01561-e1620","journal-title":"J Virol"},{"issue":"4","key":"1892_CR59","doi-asserted-by":"publisher","first-page":"e02062","DOI":"10.1128\/JVI.02062-18","volume":"93","author":"I Akhrymuk","year":"2019","unstructured":"Akhrymuk I et al (2019) Novel mutations in nsP2 abolish chikungunya virus-induced transcriptional shutoff and make the virus less cytopathic without affecting its replication rates. J Virol 93(4):e02062-e2118","journal-title":"J Virol"},{"key":"1892_CR60","first-page":"4E","volume":"4","author":"NC Ammerman","year":"2008","unstructured":"Ammerman NC, Beier-Sexton M, Azad AF (2008) Growth and maintenance of Vero cell lines. Curr Protoc Microbiol 4:4E","journal-title":"Curr Protoc Microbiol"},{"issue":"5","key":"1892_CR61","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1002\/jmv.21663","volume":"82","author":"M Khan","year":"2010","unstructured":"Khan M et al (2010) Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against Chikungunya virus in vero cells. J Med Virol 82(5):817\u2013824","journal-title":"J Med Virol"},{"key":"1892_CR62","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ et al (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69","journal-title":"Virol J"},{"issue":"16","key":"1892_CR63","doi-asserted-by":"publisher","first-page":"4585","DOI":"10.1093\/emboj\/17.16.4585","volume":"17","author":"L DeTulleo","year":"1998","unstructured":"DeTulleo L, Kirchhausen T (1998) The clathrin endocytic pathway in viral infection. Embo J 17(16):4585\u20134593","journal-title":"Embo J"},{"issue":"7","key":"1892_CR64","doi-asserted-by":"publisher","first-page":"e11479","DOI":"10.1371\/journal.pone.0011479","volume":"5","author":"E Bernard","year":"2010","unstructured":"Bernard E et al (2010) Endocytosis of chikungunya virus into mammalian cells: role of clathrin and early endosomal compartments. PLoS ONE 5(7):e11479","journal-title":"PLoS ONE"},{"issue":"5","key":"1892_CR65","doi-asserted-by":"publisher","first-page":"268","DOI":"10.3390\/v10050268","volume":"10","author":"P Roques","year":"2018","unstructured":"Roques P et al (2018) Paradoxical effect of chloroquine treatment in enhancing chikungunya virus infection. Viruses 10(5):268","journal-title":"Viruses"},{"key":"1892_CR66","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.coviro.2014.04.011","volume":"8","author":"S Beaucourt","year":"2014","unstructured":"Beaucourt S, Vignuzzi M (2014) Ribavirin: a drug active against many viruses with multiple effects on virus replication and propagation. Molecular basis of ribavirin resistance. Curr Opin Virol 8:10\u201315","journal-title":"Curr Opin Virol"},{"issue":"12","key":"1892_CR67","doi-asserted-by":"publisher","first-page":"6895","DOI":"10.1073\/pnas.111085598","volume":"98","author":"S Crotty","year":"2001","unstructured":"Crotty S, Cameron CE, Andino R (2001) RNA virus error catastrophe: direct molecular test by using ribavirin. Proc Natl Acad Sci USA 98(12):6895\u20136900","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"1892_CR68","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.1128\/JVI.02280-08","volume":"83","author":"KD Ibarra","year":"2009","unstructured":"Ibarra KD, Pfeiffer JK (2009) Reduced ribavirin antiviral efficacy via nucleoside transporter-mediated drug resistance. J Virol 83(9):4538\u20134547","journal-title":"J Virol"},{"issue":"6","key":"1892_CR69","doi-asserted-by":"publisher","first-page":"e11265","DOI":"10.1371\/journal.pone.0011265","volume":"5","author":"NR Shah","year":"2010","unstructured":"Shah NR, Sunderland A, Grdzelishvili VZ (2010) Cell type mediated resistance of vesicular stomatitis virus and Sendai virus to ribavirin. PLoS ONE 5(6):e11265","journal-title":"PLoS ONE"},{"key":"1892_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2019.04.002","volume":"167","author":"J Huchting","year":"2019","unstructured":"Huchting J et al (2019) Cell line-dependent activation and antiviral activity of T-1105, the non-fluorinated analogue of T-705 (favipiravir). Antiviral Res 167:1\u20135","journal-title":"Antiviral Res"}],"container-title":["Virus Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-022-01892-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11262-022-01892-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11262-022-01892-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T07:04:42Z","timestamp":1744182282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11262-022-01892-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,26]]},"references-count":70,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["1892"],"URL":"https:\/\/doi.org\/10.1007\/s11262-022-01892-x","relation":{},"ISSN":["0920-8569","1572-994X"],"issn-type":[{"value":"0920-8569","type":"print"},{"value":"1572-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,26]]},"assertion":[{"value":"28 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest. The authors declare that there is no financial or personal relationship with other people or organisations that could inappropriately influence the work. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by Bundeswehr Joint Medical Service or any other governmental institutions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All human cell lines used in this study are commercially available and their origin have been stated in the Materials and Methods section. A wt CHIKV was isolated from a diagnostic sample. No patient metadata was collected. No studies with human participants were conducted. Patient consent was obtained according to the national rules for the collection and prior to performing the diagnostic investigation.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}